Asensus Surgical, Inc. (ASXC)

1 member of Congress has disclosed 2 trades in Asensus Surgical, Inc. (ASXC) via STOCK Act filings. The most recent disclosure was a sale by Kevin Hern on 20 December 2021. Aggregate disclosed activity totals roughly $175K in purchases and $32.5K in sales (midpoint estimates from bracketed disclosure amounts).

Want to automatically copy Pelosi trades?

Mirror Nancy Pelosi's portfolio with just one click on eToro.

Claim Free AssetCopy Automatically with eToro

Copy Trading does not amount to investment advice. The value of your investments may go up or down. Your capital is at risk.

Past Performance is not an indication of future results.

Price data is not available for ASXC
This ticker may have been delisted, renamed, or is not publicly quoted, so no live price, statistics or chart can be shown. The congressional trades disclosed for it are listed below.

Congressional Trading Activity for ASXC

2 transactions
Compliance: 100%
Kevin Hern20 Dec 202111 Jan 2022SaleStock$15,001 - $50,000N/A
Kevin Hern25 Jun 202114 Jul 2021PurchaseStock$100,001 - $250,000N/A

Stock Overview

Market Data

Market Cap

$94.92M

Volume

3.94M

Beta

1.38

P/E Ratio

-1.12

Fundamentals

EPS

$-0.31

Div. Yield

-

Open

$0.35

Day Range

$0.35 – $0.35

Company Information

Sector
Healthcare
Industry
Medical - Devices
Exchange
AMEX · USD
Country
US
CEO
Anthony Fernando
IPO Date
1991-08-06
Website
www.asensus.com

Asensus Surgical, Inc., a medical technology enterprise established in 2006 and headquartered in Durham, North Carolina, focuses on the research, development, and commercialization of robotic medical devices. Its core mission is to elevate minimally...

Earnings

Recent Quarters

Q2 202413 Aug
EPS$-0.07
Miss 40.0%
Q1 202414 May
EPS$-0.07
Miss 40.0%
Q4 202321 Mar
EPS$-0.07
Miss 40.0%
Q3 202314 Nov
EPS$-0.06
Beat 14.3%
Q2 202310 Aug
EPS$-0.09
Miss 12.5%
Q1 202311 May
EPS$-0.09
Miss 28.6%
Q4 20222 Mar
EPS$-0.07
Beat 0.0%
Q3 202210 Nov
EPS$-0.07
Beat 0.0%
Q2 20228 Aug
EPS$-0.07
Beat 12.5%
Q1 20224 May
EPS$-0.07
Beat 12.5%
Q4 202128 Feb
EPS$-0.07
Beat 0.0%
Q3 20213 Nov
EPS$-0.06
Beat 0.0%
Q2 20215 Aug
EPS$-0.05
Beat 16.7%
Q1 202111 May
EPS$-0.06
Beat 14.3%
Q4 202011 Mar
EPS$-0.09
Beat 18.2%
Q3 20205 Nov
EPS$-0.12
Beat 47.8%
Q2 20205 Aug
EPS$-0.21
Beat 44.7%
Q1 202014 May
EPS$-0.41
Miss 5.1%
Q4 201916 Mar
EPS$-0.83
Miss 33.9%
Q3 201912 Nov
EPS$-1.17
Miss 15.8%
Q2 20197 Aug
EPS$-1.17
Miss 12.5%
Q1 20199 May
EPS$-1.17
Miss 9.3%
Q4 201826 Feb
EPS$-0.91
Miss 9.6%
Q3 20188 Nov
EPS$-0.78
Beat 11.4%
Q2 20187 Aug
EPS$-0.78
Beat 0.0%
Q1 20188 May
EPS$-0.78
Beat 21.2%
Q4 20178 Mar
EPS$-5.20
Miss 471.4%
Q3 20179 Nov
EPS$-3.38
Miss 188.9%
Q2 20172 Aug
EPS$-1.43
Miss 2.1%
Q1 201710 May
EPS$-1.69
Miss 13.4%
Q4 20166 Mar
EPS$-1.56
Miss 6.8%
Q3 20169 Nov
EPS$-1.43
Miss 10.0%
Q2 20165 Aug
EPS$-1.30
Beat 32.6%
Q1 201610 May
EPS$-1.56
Beat 9.8%
Q4 20153 Mar
EPS$-1.69
Miss 8.3%
Q3 20159 Nov
EPS$-2.08
Miss 35.1%
Q2 20156 Aug
EPS$-1.82
Beat 3.7%
Q1 20156 May
EPS$-2.08
Beat 5.0%
Q4 201420 Feb
EPS$-1.56
Beat 34.5%
Q3 20146 Nov
EPS$-2.34
Miss 3.1%
Q2 20146 Aug
EPS$-2.34
Miss 35.3%
Q1 20148 May
EPS$-0.15
Q1 20147 May
EPS$-1.95
Miss 9.6%
Q3 201314 Nov
EPS$-1.06
Q2 201314 Aug
EPS$-0.89
Q1 201315 May
EPS$-0.52
Q1 20131 Apr
EPS$-1.55
Q3 201214 Nov
EPS$-1.28
Q2 201214 Aug
EPS$-0.21
Q1 201215 May
EPS$-0.28
Q4 201129 Mar
EPS$-2.76
Q3 201114 Nov
EPS$-0.27
Q2 201112 Aug
EPS$-0.24
Q1 201116 May
EPS$-0.24
Q4 201030 Mar
EPS$-2.93
Q3 201012 Nov
EPS$-0.37
Q2 201013 Aug
EPS$-0.37
Q1 201014 May
EPS$-0.25
Q4 200931 Mar
EPS$0.90
Q3 200912 Nov
EPS$-0.20
Q2 20097 Aug
EPS$-0.28
Q1 200913 May
EPS$-0.25
Q4 200827 Mar
EPS$-4.41
Q3 200813 Nov
EPS$-0.31
Q2 20088 Aug
EPS$-0.42
Q1 200813 May
EPS$-0.45
Q4 200726 Mar
EPS$-4.83
Q3 200720 Nov
EPS$-0.31
Q2 20071 Aug
EPS$-0.03
Q1 200720 Apr
EPS$0.00
Q1 20072 Apr
EPS$-2.45
Q3 200625 Oct
EPS$-0.01
Q2 200628 Jul
EPS$0.00
Q4 200531 Mar
EPS$0.31
Q3 200510 Nov
EPS$-0.09
Q2 200511 Aug
EPS$-0.08
Q1 200516 May
EPS$-0.19
Q4 200431 Mar
EPS$-0.24
Q3 200415 Nov
EPS$-0.34
Q2 20042 Aug
EPS$-0.30
Q1 200417 May
EPS$-0.26
Q4 200330 Mar
EPS$-1.71
Q3 200314 Nov
EPS$-0.49
Q2 200313 Aug
EPS$-0.66
Q1 20037 May
EPS$-0.82
Q4 200231 Mar
EPS$-76.91
Q3 20028 Nov
EPS$-1.71
Q2 20027 Aug
EPS$-2.18
Q1 200215 May
EPS$-2.14
Q4 200127 Mar
EPS$2.16
Q3 20017 Nov
EPS$0.18
Q2 20013 Aug
EPS$1.10
Q1 200115 May
EPS$-0.11
Q4 200029 Mar
EPS$-0.68
Q3 200014 Nov
EPS$0.14
Q2 200011 Aug
EPS$3.95
Q1 20009 May
EPS$1.41
Q4 199929 Mar
EPS$16.55
Q3 199912 Nov
EPS$1.70
Q2 199913 Aug
EPS$1.50
Q1 199914 May
EPS$1.15
Q4 199830 Mar
EPS$-80.73
Q3 199812 Nov
EPS$-5.50
Q2 199814 Aug
EPS$-8.50
Q1 199818 May
EPS$-52.00
Miss 500.0%
Q4 199731 Mar
EPS$-104.00
Miss 166.7%
Q3 19977 Nov
EPS$-136.50
Miss 281.8%
Q2 199731 Jul
EPS$-26.00
Beat 29.4%
Q1 199715 May
EPS$9.50
Q1 19971 May
EPS$123.50
Beat 29.6%
Q3 199614 Nov
EPS$0.23
Q2 199614 Aug
EPS$-4.50
Q1 199615 May
EPS$-6.00
Q3 199531 Dec
EPS$15.60
Q2 199530 Sept
EPS$-3.00
Q1 199530 Jun
EPS$1.00
Q4 199431 Mar
EPS$0.50
Q3 199431 Dec
EPS$3.25
Q2 199430 Sept
EPS$6.00
Q1 199430 Jun
EPS$-1.50
Q4 199331 Mar
EPS$-1.50
Q3 199331 Dec
EPS$-3.25
Q2 199330 Sept
EPS$-1.00
Q1 199330 Jun
EPS$-1.00
Q4 199231 Mar
EPS$-1.50
Q3 199231 Dec
EPS$-23.40
Q2 199230 Sept
EPS$-1.00
Q1 199230 Jun
EPS$-1.00
Q4 199131 Mar
EPS$-1.50
Q3 199131 Dec
EPS$-13.00
Q2 199130 Sept
EPS$-25.79
Q1 199130 Jun
EPS$-39.00
Q4 199031 Mar
EPS$-26.00
Q3 199031 Dec
EPS$-1.63
Q2 199030 Sept
EPS$-2.00
Q1 199030 Jun
EPS$-2.00
Q4 198931 Mar
EPS$-2.00

No dividend data available for this stock.

Stock Splits

Split History

12 Dec 2019Reverse Split
Ratio1:13
2 Apr 2014Reverse Split
Ratio1:5
5 Jan 1999Reverse Split
Ratio1:10
28 Jun 1996Stock Split
Ratio2:1
16 Feb 1994Stock Split
Ratio2:1

Similar Stocks

Based on congressional trading patterns

Smart Recommendations
No similar stocks found
No congressional trading patterns available for recommendations

Frequently Asked Questions about ASXC

Which members of Congress have traded ASXC?
1 member of Congress has disclosed 2 trade in Asensus Surgical, Inc. (ASXC) under the STOCK Act: Kevin Hern.
When was ASXC most recently disclosed by Congress?
The most recent ASXC disclosure was a sale by Kevin Hern on 20 December 2021.
What is the total disclosed congressional trading volume for ASXC?
Members of Congress have disclosed approximately $175K in ASXC purchases and $32.5K in sales. These figures are midpoint estimates derived from the bracketed amount ranges used in STOCK Act filings.
How can I track new congressional trades in ASXC?
This ASXC page updates as soon as new STOCK Act disclosures are filed for Asensus Surgical, Inc.. Every trade, politician, transaction date and amount range is surfaced above, typically within hours of the official filing appearing on the House or Senate disclosure portals.
Pelosi Tracker
PoliticiansBillsArticlesPortfoliosPricingAboutLegalTerms of ServicePrivacy Policy
Français
© 2026 - All rights reserved. Powered by Vantara Labs
Pelosi Tracker is an independent, third-party platform. It is not affiliated with, endorsed by, or in any way associated with Nancy Pelosi, her office or her representatives, or with any other member of Congress. Any use of her name is solely for the purpose of discussing publicly available information.The information provided by Pelosi Tracker is for informational and educational purposes only and is not intended to serve as, nor should it be construed as, financial or investment advice. The data presented here is sourced from publicly available filings and records. While we strive for accuracy, timeliness, and completeness, we do not guarantee that all information is error-free or current.